Daikyo Seiko

Sano, Japan Founded: 1954 • Age: 72 yrs
Pharmaceutical packaging and medical device components are manufactured.

About Daikyo Seiko

Daikyo Seiko is a company based in Sano (Japan) founded in 1954. Daikyo Seiko offers products and services including Laminated Rubber Stoppers and CZ Vials.

  • Headquarter Sano, Japan
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website daikyoseiko.jp
  • Legal Name 株式会社大協精工
  • Date of Incorporation 10 Aug, 1977
  • Jurisdiction Maharashtra, India
Key Metrics

Products & Services of Daikyo Seiko

Daikyo Seiko offers a comprehensive portfolio of products and services, including Laminated Rubber Stoppers and CZ Vials.

Laminated Rubber Stoppers
Medical Packaging

High-quality rubber stoppers are manufactured for pharmaceutical applications to ensure functionality and safety

CZ Vials
Medical Packaging

CZ vials are produced for use in medical and pharmaceutical contexts to support packaging needs

Funding Insights of Daikyo Seiko

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Daikyo Seiko with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2019–Private Equity Round–West Pharmaceutical Services
–
Valuation history

1 investors in total: 1 institutional.

Investors in Daikyo Seiko

Daikyo Seiko has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include West Pharmaceutical Services.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Injectable packaging, containment, and delivery solutions are manufactured.
1923westpharma.comExton, United States
Premium access

Investor details for Daikyo Seiko

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Daikyo Seiko

1 people are tracked at Daikyo Seiko (1 in leadership).

NameRoleGroup
Hiroshi Togashi
Managing DirectorLeadership
Premium access

Complete people profiles for Daikyo Seiko

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Daikyo Seiko

2 dated milestones of Daikyo Seiko across 65 years, from founding to its latest funding, stage changes and deals.

  1. Founded Daikyo Seiko is founded.
  2. Funding First funding round.

Web traffic of Daikyo Seiko

The website of Daikyo Seiko (daikyoseiko.jp) receives about 2.3K visits a month and ranks #5,385,457 among all websites worldwide, #6,044 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    2.3K
  • Unique visitors
    1K

    per month

  • Global rank
    #5,385,457

    among all websites

  • Category rank
    #6,044

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Daikyo Seiko. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
westpharma.com
88%
101.1K#397,912View details

Similar companies to Daikyo Seiko

10 companies that operate in the same segment as Daikyo Seiko (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Daikyo Seiko

Daikyo Seiko was founded in 1954 and raised its 1st funding round 65 years after it was founded.

Daikyo Seiko is headquartered in Sano, Japan. It is registered at Sano, Tochigi, Japan.

Daikyo Seiko was founded in 1954 and is based in Sano, Japan. Operations focus on the production of pharmaceutical packaging solutions and components for medical devices. Precision manufacturing processes are employed to meet industry standards in the healthcare sector. The company serves global markets through its expertise in injection molding and assembly techniques. Leadership is provided by Managing Director Hiroshi Togashi, ensuring compliance with regulatory requirements.

Daikyo Seiko offers Laminated Rubber Stoppers and CZ Vials.

Daikyo Seiko has 1 investor. Key investors include West Pharmaceutical Services.

Daikyo Seiko operates through ,.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available